Animal Pharm is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By


Virbac closes Pfizer deal in Australia

Virbac has completed its acquisition of Pfizer veterinary assets in Australia after the agreement was cleared by the competition authorities. The portfolio of livestock products and related assets, including a manufacturing facility, were divested by Pfizer as a condition of the take over of Wyeth and its Fort Dodge animal health business. The products, which were marketed in Australia by Fort Dodge, include parasiticides and vaccines, mainly for cattle and sheep, and achieved net sales of around A$36 million (US$28.5 million) in 2009.


What to read next




Ask The Analyst

Please fill in the form below to send over your enquiry or check the Ask The Analyst Page to find out more about the service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts